Wednesday, December 21, 2005
Collagenex to raise $29m
Collagenex, the guys who recently acquired SansRosa and who are behind the oracea periostat variant, have raised $29m by selling new shares into the market.
Their shares are currently trading at $11.75; it will be interesting to see how the shares perform from now on. The company has been in the process of re-inventing itself recently. I guess if you believe in the products and the size of the rosacea market they may make an interesting investment.
Original report here:
http://www.businessweek.com/ap/financialnews/D8EKOGT00.htm?campaign_id=apn_home_down&chan=db
Collagenex Share price: http://uk.finance.yahoo.com/q/bc?s=CGPI&t=3m&l=on&z=m&q=l&c=
Previously...
Our first post on SansRosa.
Transcript of interview with SansRosa founder.
WindHover report on SansRosa.
SansRosa patents.
Their shares are currently trading at $11.75; it will be interesting to see how the shares perform from now on. The company has been in the process of re-inventing itself recently. I guess if you believe in the products and the size of the rosacea market they may make an interesting investment.
Original report here:
http://www.businessweek.com/ap/financialnews/D8EKOGT00.htm?campaign_id=apn_home_down&chan=db
Collagenex Share price: http://uk.finance.yahoo.com/q/bc?s=CGPI&t=3m&l=on&z=m&q=l&c=
Previously...
Our first post on SansRosa.
Transcript of interview with SansRosa founder.
WindHover report on SansRosa.
SansRosa patents.
